Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 6, 2011, Pages 500-506

  Naidu, Rakesh ^a   Har, Yip C ^b,c   Taib, Nur A M ^b,c  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Breast cancer; genotyping; PCR RFLP; PIN1; polymorphism

Indexed keywords

ESTROGEN RECEPTOR; ISOMERASE; PEPTIDYL PROPYL ISOMERASE 1; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; LYMPHATIC METASTASIS; MALAYSIA; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PEPTIDYLPROLYL ISOMERASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 80052946273     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.590223     Document Type: Article

References (24)

1. Galat A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Curr Top Med Chem 2003;3:1315-47.
2. Lu KP, Suizu F, Zhou XZ, Finn G, Lam P, Wulf G. Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol Carcinog 2006;45:397-402. (Pubitemid 43865846)
3. Lu KP, Liou YC, Zhou XZ. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 2002;12:164-72. (Pubitemid 34442238)
4. Yeh ES, Means AR. PIN1, the cell cycle and cancer. Nat Rev Cancer 2007;7:381-8. (Pubitemid 46652482)
5. Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerise essential for regulation of mitosis. Nature 1996;380:544-7 (Pubitemid 26111332)
6. Ranganathan R, Lu KP, Hunter T, Noel JP. Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell 1997;89:875-86. (Pubitemid 27513514)
7. Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld JU, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC, Lu KP. Sequence specifi c and phosphorylationdependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997;278:1957-60. (Pubitemid 28013239)
8. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang D. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 2004;164:1727-37. (Pubitemid 38529775)
9. Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 2003;63:6244-51. (Pubitemid 37255170)
10. Wulf G, Garg P, Liou YC, Iglehart D, Lu KP. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 2004;23:3397-407. (Pubitemid 39209163)
11. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Lu KP. Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J 2001;20:3459-72. (Pubitemid 32634353)
12. Ryo A, Liou YC, Wulf G, Nakamura N, Lee SW, Lu KP. Pin1 is an E2F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 2002;22:5281-95. (Pubitemid 34755742)
13. Segat L, Milanese M, Crovella S. Pin1 promoter polymorphisms in hepatocellular carcinoma patients. Gastroenterology 2007;132:2618-2619. (Pubitemid 46900822)
14. Han CH, Lu J, Wei Q, Bondy ML, Brewster AM, Yu TK, Buchholz TA, Arun BK, Wang LE. The functional promoter polymorphism (2842G- C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat 2010; 122:243-9.
15. Lu J, Hu Z, Wei S, Wang LE, Liu Z, El-Naggar AK, Sturgis EM, Wei Q. A novel functional variant (-842G/C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis 2009;30:1717-21.
16. Segat L, Pontillo A, Annoni G, Trabattoni D, Vergani C, Clerici M, Arosio B, Crovella S. PIN1 promoter polymorphisms are associated with Alzheimers disease. Neurobiol Aging 2007;28:69-74. (Pubitemid 44802916)
17. Lim GCC, Halimah Y. Second Report of the National Cancer Registry. Cancer Incidence in Malaysia 2003. National Cancer Registry. Kuala Lumpur, 2004.
18. Naidu R, Har YC, Taib NA. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development. Oncol Res 2009;18(2-3):65-71.
19. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. Histopathology 1991;19:403-10.
20. Bloom HI, Richardson WW. Histological grading and prognosis. Br J Cancer 1957;11:359-77.
21. American Joint Committee on Cancer. Breast. In AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002:171-80.
22. Singletary ES, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge BS, Hayes DF, Hughes LL, Hutter RVP, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver H, Wieland S, Greene FL. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628-36. (Pubitemid 34983222)
23. Naidu R, Har YC, Taib NA. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. J Exp Clin Cancer Res 2007; 26:133-40. (Pubitemid 46650054)
24. Lambert JC, Bensemain F, Chapuis J, Cottel D, Amouyel P. Association study of the PIN1 gene with Alzheimers disease. Neurosci Lett 2006;402:259-61. (Pubitemid 43850162)